Home › Funds › JGP Wealth Management, LLC › ABT

JGP Wealth Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

JGP Wealth Management, LLC reported holding 60,922 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$6.0M, representing 0.53% of its reported portfolio and ranking #44 among its reported holdings. JGP Wealth Management, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)60.92K sh
Reported value held$6.02M
Portfolio Weight0.53%
First reportedQ3 2023
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How JGP Wealth Management, LLC's ABT position evolved

JGP Wealth Management, LLC first disclosed a stake in ABT in Q3 2023 at 92,331 shares (US$8.9M). The position peaked in Q2 2025 at 84,693 shares, worth US$11.5M. Across 13 filings, JGP Wealth Management, LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 60,922 shares valued at US$6.0M. Notable position changes include a 28% trim in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 92.33K $8.94M New
Q4 2023 90.41K $9.95M Reduce
Q1 2024 87.39K $9.93M Reduce
Q2 2024 88.75K $9.22M Add
Q3 2024 91.04K $10.38M Add
Q4 2024 92.42K $10.45M Add
Q1 2025 85.05K $11.28M Reduce
Q2 2025 84.69K $11.52M Hold
Q3 2025 84.88K $11.29M Hold
Q4 2025 86.34K $10.82M Add
Q1 2026 84.59K $8.69M Reduce
Q2 2026 60.95K $5.53M Reduce
Q3 2026 60.92K $6.02M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has JGP Wealth Management, LLC held ABT?

JGP Wealth Management, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is JGP Wealth Management, LLC's current position in ABT?

As of Q3 2026, JGP Wealth Management, LLC holds 60.92K shares of ABT (ABBOTT LABORATORIES), valued at $6.02M, representing 0.53% of its reported portfolio and ranking #44.

Has JGP Wealth Management, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), JGP Wealth Management, LLC held unchanged its position in ABT. The position peaked in Q2 2025 at 84.69K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.